News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | DNA methylation-based measures of biological aging and cognitive decline over 16-years: preliminary longitudinal findings in midlife

Aging

December 29, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 23, entitled, “DNA methylation-based measures of biological aging and cognitive decline over 16-years: preliminary longitudinal findings in midlife.” continue reading »

Oncotarget | Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients

News

December 29, 2022
PRESS RELEASE: On December 17, 2022, a new research paper was published in Oncotarget, entitled, “Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients.” continue reading »

Oncotarget | The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

News

December 28, 2022
PRESS RELEASE: On December 17, 2022, a new research paper was published in Oncotarget, entitled, “The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies.” continue reading »

Oncoscience | Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective

News

December 27, 2022
PRESS RELEASE: On December 21, 2022, a new research perspective was published in Oncoscience, entitled, “Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective.” continue reading »

Oncotarget | Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget

December 22, 2022
PRESS RELEASE: A new research paper was published in Oncotarget, entitled, “Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.” continue reading »